The aim of this article is to describe the history of brachytherapy in Poznań from the beginning of 20 th century. Among the most important medical and oncological institutions that were created in Poznań at the beginning of twentieth century were: Surgical Clinic of Poznań University (City Hospital, Poznań), Transfiguration of the Lord Hospital (Poznań) and Radiology Faculty of Poznań University (Poznań). After the World War II in 1953 at Garbary Street hospital three new departments were established: Surgery, Gynecology and General Departments. At that time, radium treatment was introduced to Gynecology and General Departments and it was applied in therapy till the early nineties, in spite of introducing LDR and HDR brachytherapy in seventies and eighties. The intense development of brachytherapy took place in late nineties, when brachytherapy treatment of non-gynecological tumors started. Today's condition of brachytherapy at Greater Poland Cancer Centre (GCC) is presented in this article, too.
Purpose
Brachytherapy has its own place in history, since Maria Skłodowska-Curie discovered radium at the turn of nineteenth century. Maria Skłodowska-Curie (born in Warsaw, 1867) was first out of many women to win the recognition of world science (Figs. 1-2). Graduated from Sorbonne, Paris, Skłodowska-Curie was conducting pioneer researches with radioactive elements such as radium and Review articles polonium, which helped to understand physical phenomenon of radioactivity. In the whole history of science she was truly a remarkable woman and probably the most famous one as well. She was the first woman in Europe to obtain natural science doctorate degree and at the same time first women to win Nobel Prize in physics (1903) . She was the first woman-lecturer, professor and Head of Laboratory at Sorbonne, Paris and first person ever to win twice the Nobel Prize (1911 -second Nobel Prize in chemistry). She was also the first mother of daughter-Nobel Prize winner and first woman buried at Parisian Pantheon. Almost 100 years old history of brachytherapy in Poznań is worth studying and investigating. Its development as well as progress in this field in Poland is credited to Maria Skłodowska-Curie.
At the beginning of twentieth century
Till the year of 1932, approximately 3 grams of radium was gathered in Poland (Fig. 3) . However, the fact of its dividing and dispersal within several institutions as well as preparation activity, totally unadapted to control treatment and complete lack of knowledge in matter of impact of radiation on human tissues, caused -as recalled by the first director of Radiation Institute, prof. Franciszek Łukaszczyk (1897-1956) -obtained results to be far from regularity, in most of the cases accidental; many of the doctors were to pay for their work with disability or death [1] . Radiological Laboratory which opened in 1913 in Warsaw as a part of Warsaw Science Society was the main institution for physical researches of radium radioactivity. Till the 1926 the official Head of this Laboratory was Maria Skłodowska-Curie, after that year she was the Honorary Head of this institution. She donated 100 mg of radium bromide to the Radiological Laboratory. Upon her wish and under her honorary presidency, in 1921 a legal unit was created called Radium Institute Society. In December 1923, on 25 th anniversary of radium discovery, Cancer Combat Polish Committee issued an appeal to the Polish community to raise funds for "Nation Gift for Maria Skłodowska-Curie" which was the Maria Skłodowska-Curie Radium Institute. The scientist turned for help to a famous American journalist Ms. Maloney and thanks to well organized subscription among Poles in America and friends of Poland, enough of funds were raised to purchase 1 gram of radium. In 1929 Maria Skłodowska-Curie received these funds from the President of the United States -Herbert Hoover, who strongly supported the subscription. Radium of total weight of 1033,21 mg was purchased in Belgian factory "Union Miniere du Haut Katanga" and the price was reduced exclusively for Maria Skłodowska-Curie. The radioactive element was in a set of tubes and needles which allowed so called "Parisian way of treatment" and was labeled as a RMS (abbreviation: Maria Skłodowska Radium) [1] . The first "European" radium that was manufactured by Maria Skłodowska-Curie originated from Czech uranium ore, extracted from Joachimowa. At that time uranium ore was mine also in Belgian Kongo and in Colorado, USA and was sent by waterway to chemical factory in Oolen, Antwerp [2, 3] .
According to Supady [4] [2] . He was among the first scientists in the world who evolved theoretical foundations and introduced to clinical practice rotating therapy of X-rays (1933) and radium (1939) . He also published his scientific results of tumor treatment with the use of different therapy methods [2, 3] . Another outstanding individuality among radiologists of non-university trend was Tadeusz Alkiewicz, who since 1921 was the owner of Radiology Department that treated patients throughout inter-war period. He was also the co-founder of Polish Medical Radiologic Association. From 1924 he was administrating Radiology Department of 7 th Army District Hospital and conducting radiographic diagnostics and radium therapy at Elisabeth Sisters Hospital. At that time, Warsaw and Poznań -as a academic cities -were in the lead in providing the most resilient radiological units [2] . Dr Tadeusz Alkiewicz was writing about radioactive bodies in a 15 th issue of magazine "Greater Poland 
After II World War
Unfortunately, there is not much informations about radiotherapy in Poznań in years 1945-1952, but it this a well known fact that between 1947 and 1948, as a part of international help from UNRRA (United Nations Relief and Rehabilitation Administration), three transports of radium arrived from Canada. At that time Poland received 17 gram of radium and that was the actual foundation for organizing a domestic chain of oncologic centers. In 1952, for the first time since the war, a cancer prevention campaign was created and it recommended to establish new Oncological Centre in Poznań. In January 1952 dr Czesław Wojnerowicz, who during German occupation worked at Radium Institute in Warsaw, was leading the initial organizing work for the new Hospital [2, 3] . In March 1952 a decision was taken in order to transform Life Insurance Hospital in Poznań at Garbary Street (previously Raczyński Street), into a medical oncologic institution. At the end of 1953, three departments were already operating: Gynecologic, General and Surgery with 100 beds in total. Laboratory of Clinical Pathology was formed and Curie-therapy rooms (Gynecologic and General Departments) were partially equipped. In 1958-1959 the Radiotherapy Department was reconstructed and outfitted with four deep X-ray therapy and one superficial therapy apparatuses. In radium therapy rooms a prototypical automatic protective devises were used which reduced the risk of staff exposure to the radioactive beams. From 1953 till 1978, the total amount of 1 020 353 of irradiative sessions was carried out, in which 750 029 of X-ray sessions, 258 809 of cobalt sessions and 11 246 of caesium sessions. However, radium irradiations were applied to 13 160 patients. Figure 6 shows the total amount of radium treated patients in years 1974-1984. Within years 1953-1978, Oncologic Gynecology Department treated patients with gynecological tumors, that were not qualified for surgery. Pre-surgery radium irradiation was also used. The preliminary independent beam treatment that include radium application, telegammatherapy and History of brachytherapy in Greater Poland Cancer Centre radium beam treatment followed by cobalt and ceasium therapy, were initially conducted according to modified Parisian technique. Later on, the Heyman's method (Stockholm) was used [2, 3] . General Oncologic Department treated patients with all types of tumors, qualified to beam therapy as an exclusive way of treatment, but also as a combined treatment with chemotherapy and surgery. The Department was in possession of radiation sources used for lips and mouth brachytherapy. Unfortunately, no published treatment results of that time are available at present [2, 3] .
Nowadays
The Greater Poland Cancer Centre admitted his first patients in the early fifties. From that time onward, brachytherapy was present in the treatment of malignant cancers, in which radium was used as a basic way of therapy. During that time, till the nineties, brachytherapy was used only in cases of gynecologic tumors. In the seventies, the Centre bought his first LDR selectron, equipped with 137-Cesium isotope. This significant purchase allowed safe and automatic use of radiation sources. In the nineties, after getting devices of new generation -HDR and PDR microselectrons, the amount of treated patients increased essentially. The range of tumors treatment was widely extended to meet the standard level of renowned Cancer Centers of European Union.
On the 8 th of May 1999, for the first time brachytherapy was used in non-gynecological tumors -in advanced lung cancer. Brachytherapy Laboratory was created, as a part of 1 st General Radiotherapy Unit and was operating till the 1 st of June 2005. During 6 years of operational time of the Laboratory, two doctors were engaged in non-gynecological brachytherapy: Janusz Skowronek, MD, and Krystyna Adamska, MD, along with the nurses: Lidia Rogozik, Barbara Majewska and Emilia Szczepka. With great collaboration of medical physicist -Grzegorz Zwierzchowski, MD, who is working in the Department from the beginning. The entire team has introduced to clinical practice many innovative ways of brachytherapy, such as: development of Pulsed Dose Rate (PDR) brachytherapy as one of the first Centers in Poland, endovascular brachytherapy and new technique of billiary ducts brachytherapy. For the first time PDR therapy was used in treatment of malignant glioma recurrences. Significant part of all our patients with advanced lung cancers and oesophageal cancers had a chance to receive palliative HDR treatment [7] .
The 12. Endoluminal and interstitial brachytherapy of anal cancer. 13. Endoluminal and interstitial brachytherapy of gynecological cancers (Department of Gynecological Radiotherapy). 14. Interstitial and superficial hyperthermia combined with brachytherapy, EBRT and/or chemotherapy. 15. Diagnostic and therapeutic bronchoscopy [7] .
Brachytherapy Department Structure
The GCC Brachytherapy Department contains two bunkers devoted to HDR brachytherapy; one for PDR brachytherapy (the second one is in Gynecological Department), operating theatre for placing applications under local or general anesthesia; Laboratory of Treatment Planning and Brachytherapeutic Dosimetry (under auspices of Medical Physics Department); Laboratory of Hyperthermia; Laboratory of Endoscopy; out-patient clinic; two wards (6 beds); duty room; nurse's station; secretary's office, Head of Department's Office; archives (Figs. 9-10 ). The GCC enclose four professional brachytherapy devices: two units of microselectrons HDR (High Dose Rate), microselectron PDR (Pulsed Dose Rate) and selectron LDR (Low Dose Rate) -both located in a shielding rooms of Gynecological Radiotherapy Department (Head; Andrzej Roszak, MD, PhD, Ass. Prof.). The purchase of second PDR unit is in future plans.
The Department is in possession of modern technology appliances, such as computer software for treatment planning: PLATO, Oncentra Masterplan, Oncentra Prostate, Anatomy Modeling, Integrated Brachytherapy Unit (IBU); a device for radiological verification: PHILIPS ENDURA; two "real time" planning systems: SWIFT for brachytherapy of prostate cancer, and SPOT software for permanent implants treatment (Figs. 11-14) .
The Staff
Brachytherapy procedures demands close collaboration of all team members. In GCC, brachytherapy is conducted by a team of highly specialized medical staff that includes physicians (radiation oncologists), medical physicists, X-ray technicians and nurses. Additionally, the team is in constant cooperation with a consultant pulmonologist. Our personnel is trained in the best national and foreign Centers. The staff includes: 5 physicians (additionally 2 in Gynecological Department), 4 medical physicists, 13 nurses, X-ray technicians and 2 medical secretaries [7] (Fig. 15) .
The Scientific Research
Over forty scientific articles have been published by our team members from 1999 till 2007. We prepared more than 80 conference presentations and lectures relating to brachytherapy. The Head of the Department completed his registration and conferment procedure for an assistant professor degree. Other doctoral degrees are presently being conducted. All members of the Department take active part in annual Polish and International scientific conferences. The Department takes part in a multicentric trials, such as phase II study (PBIG Trial) on prostate cancer HDR monotherapy. The team members are also involved in numerous EU projects like EMPIRION or QUESTRO. The Department provides classes given to medical, health science and biotechnology students from University of Medical Sciences in Poznań as well as to physics students from Poznań and Torun Universities.
Cooperation
The staff of GCC Brachytherapy Department gain and expand their experience and knowledge in collaboration with other Polish and foreign Centers, especially with 
Janusz Skowronek
Brachytherapy Departments in Bydgoszcz, Gliwice and Warsaw. We've also established good cooperation with Institute of Oncology in Barcelona (Spain), University of Vienna (Austria) and University of Utrecht (Netherlands). The HDR/PDR brachytherapy of central nervous system tumors is applied in collaboration with 
Introducing new treatment methods
Exceptional and outstanding achievements of GCC Brachytherapy Department team members (first introduction of treatment methods in local region) can be listed as follows: The GCC Brachytherapy Department as one out of three centers in Poland to use modern hyperthermia unit (BSD -400/500, BSD Medical) in therapy of selected group of patients. This type of treatment meets the standard level of the best equipped oncology centers in Europe (Fig. 16) .
In December 2008 as a part of Brachytherapy Department and being the first in the Mideastern Europe, we've created a diagnostic and medical background that permits the implantation of radioactive sources I-125 under the control of ultrasound TRUS in prostate cancer treatment. The GCC Brachytherapy Department is the first one in Poland to use such innovative type of treatment.
